📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti-DKK1 therapeutic DKN-01. (2023)

First Author: Jarman EJ

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/liv.15383

PubMed Identifier: 35924447

Publication URI: http://europepmc.org/abstract/MED/35924447

Type: Journal Article/Review

Volume: 43

Parent Publication: Liver international : official journal of the International Association for the Study of the Liver

Issue: 1

ISSN: 1478-3223